News

The emerging field of interventional endocrinology has the potential to revolutionize the way we treat thyroid diseases. In this interview, thyroid surgeon Jennifer Kuo, MD, discusses new non-surgical techniques that are changing treatment.

The Columbia Thyroid Biopsy Program is a leader in addressing multi-nodular thyroid disease and thyroid cancer. It offers same-day onsite evaluations, with surgeons coordinating with cytopathologists to minimize the number of biopsies required to get definitive results.

Recently Columbia oncologists diagnosed a toddler with acute myelogenous leukemia, and thanks to The Sohn Foundation for Precision Medicine, the entire family underwent genetic testing. Three of his siblings were found to have a gene linked to thyroid cancer. Their father was the carrier. Dr. Kuo found a suspicious thyroid nodule in his neck and with ultrasound-guided fine needle aspiration biopsy diagnosed medullary thyroid cancer, a rare and aggressive form of this disease. She operated the following week. “With our early intervention,” she says, “there is a very good chance that the father has been completely cured and will remain cancer-free.”

The Columbia Thyroid Center is proud to announce that Dr. James Lee, Co-Director, was honored at the SDHB Pheo-Para Coalition Gala with the Science Leadership Award on April 20th, 2017.

The NY Thyroid-Parathyroid Center will be posting a number of important blogs, patient stories, and educational pieces to help educate everyone about the presentation, screening, diagnosis, and treatment of thyroid cancer as well as to help raise awareness of this disease.

Leonardo Da Vinci: a Renaissance Man amongst renaissance men. We remember him for the Mona Lisa, the Last Supper, and…the thyroid?

The promise and perils of molecular testing

Hashimoto's thyroiditis is a chronic autoimmune disease that is believed to the leading cause of primary hypothyroidism in North America.